Tag Archives: patent claims

Siemens v. Saint-Gobain – What’s Sauce For The Goose May Leave The Gander Unscathed

Contributed by Jim Nelson, J.D., Ph.D. of Schwegman Lundberg & Woessner, P.A. The Siemens Medical Solutions USA, Inc. v. Saint-Gobain Ceramics & Plastics, Inc., (a copy is available at the end of this post) case presents a fundamental issue and … Continue reading

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , | Leave a comment

Supplementary 112 Examination Guidelines – What’s In It For Me?

This Post is from Mark Muller, Shareholder at Schwegman, Lundberg & Woessner, P.A. Supplementary examination guidelines for Section 112 were recently published in the Federal Register and sent out for public comment.  While the details may not be too exciting, … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , , , | Leave a comment

TALKING WRITTEN DESCRIPTION REQUIREMENT BLUES – ARIAD WOBBLES

On October 5, 2009, Ariad filed a 60 page brief (not counting attached appendices) with the Federal Circuit in support of its appeal in Ariad v. Lilly. (Attached below.) As you will recall from my post of August 24th, the … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , | Leave a comment

Hal Wegner Wakes Up ACI Biotech Patents Forum in Boston

On Sept. 30th, Harold C. (Hal) Wegner gave a talk on current developments that emphasized the importance of inter partes reexamination, particularly as a weapon of patent destruction. His opinion, summarized by me, is that KSR is increasingly being applied … Continue reading

Posted in Post-Grant Issues | Tagged , , , , , , | Leave a comment